The systemic effects of AKI that may contribute to mortality have been extensively investigated in preclinical models
One source says semaglutide is the answer
Real-world persistence data will be particularly important to guide efforts for shoring up the chronic market opportunity, e.g., via digital health support programmes, such as the Omada Health-Evernorth partnership [8]
If nausea , diarrhea, or constipation worsen rather than improve over 4 to 6 weeks at a stable dose, suspect issues beyond normal adaptation, including dietary factors, concurrent illness, or medication interactions
Sin embargo, su utilizacin es an ms beneficiosa en pacientes con IMC superior a 30 Kg/m2 y que se encuentran en tratamiento con insulina basal, sin haber logrado los objetivos de control glucmico establecidos en cada caso, a pesar de presentar glucemias basales adecuadas